Request for Covid-19 Impact Assessment of this Report

Healthcare

Industry Snapshot - Contrast Agent Market in China 2021

  • GEN4688489
  • 65 Pages
  • October 2021
  • Healthcare
Download Sample    Get Discount   
 
A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. In 2020, the contrast agent market in China stood at USD 2,313 million. Recording a CAGR of 11.7% from 2021 to 2027, the worth is projected to reach ~USD 5,017 million by 2027, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into contrast agent market in China. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The contrast agent market is segmented on the basis of modality, and product. The contrast agent market is segmented as below:

By modality:

- MRI

- X-ray/CT

- ultrasound

By product:

- iodixanol

- iohexol

- iopamidol

- iopromide

- ioversol

- diatrizoate

The report also provides a detailed analysis of several leading contrast agent market vendors that include Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., General Electric Company, Jiangsu Hengrui Medicine Co., Ltd., Liebel-Flarsheim Company LLC, Shanghai Bolai Kexinyi Pharmaceutical Industry Co., Ltd., Yangtze River Pharmaceutical Group Co. Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

- To analyze and forecast the market size of the contrast agent market in China.

- To classify and forecast the contrast agent market in China based on modality, and product.

- To identify and analyze the profile of leading players operating in the contrast agent market in China.

Why Choose This Report

- Gain a reliable outlook of the contrast agent market in China forecasts from 2021 to 2027 across scenarios.

- Identify growth segments for investment.

- Stay ahead of competitors through company profiles and market data.

- The market estimate for ease of analysis across scenarios in Excel format.

- Strategy consulting and research support for three months.

- Print authentication provided for the single-user license.

Part 1. Introduction

1.1 Market definition

1.2 Key benefits

1.3 Market segment

Part 2. Methodology

2.1 Primary

2.2 Secondary

Part 3. Executive summary

Part 4. Contrast agent market in China, by modality

4.1 MRI

4.1.1 Market size and forecast

4.2 X-ray/CT

4.2.1 Market size and forecast

4.3 Ultrasound

4.3.1 Market size and forecast

Part 5. Contrast agent market in China, by product

5.1 Iodixanol

5.1.1 Market size and forecast

5.2 Iohexol

5.2.1 Market size and forecast

5.3 Iopamidol

5.3.1 Market size and forecast

5.4 Iopromide

5.4.1 Market size and forecast

5.5 Ioversol

5.5.1 Market size and forecast

5.6 Diatrizoate

5.6.1 Market size and forecast

Part 6. Market share analysis

6.1 Bayer AG

6.2 Beijing Beilu Pharmaceutical Co., Ltd.

6.3 General Electric Company

6.4 Jiangsu Hengrui Medicine Co., Ltd.

6.5 Liebel-Flarsheim Company LLC

6.6 Shanghai Bolai Kexinyi Pharmaceutical Industry Co., Ltd.

6.7 Yangtze River Pharmaceutical Group Co. Ltd.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER

ABOUT GEN CONSULTING COMPANY

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950